From Burden to Breakthrough: CASGEVY’s Revolutionary Approach to β-Thalassemia and Sickle Cell Disease
Almost 20 million people around the world are living with sickle cell anemia, where roughly 60000 newborns are born with β-Thalassemia annually. The.